Latest Biotech News

Groundbreaking studies reinforce the impact of diet and behavior on chronic conditions. Multiple international studies confirm that a calorie-restricted Mediterranean diet combined with physical...

Life sciences manufacturing receives notable boosts as Thermo Fisher Scientific unveiled a new 375,000-sq-ft Center of Excellence in Mebane, North Carolina, focused on laboratory consumables such...

The U.S. Food and Drug Administration (FDA) has suspended the biologics license of Valneva SE’s chikungunya vaccine, Ixchiq, following mounting reports of serious adverse events consistent with...

Pharmaceutical giant AbbVie is advancing its neuroscience portfolio by acquiring Gilgamesh Pharmaceuticals’ experimental psychedelic compound, bretisilocin, for up to $1.2 billion including...

Researchers have utilized advanced artificial intelligence systems to uncover molecular mechanisms by which tuberculosis (TB) drugs kill Mycobacterium tuberculosis. This AI-powered analysis offers...

Leading research institutions have introduced novel computational platforms to advance cancer tissue analysis. Mount Sinai’s AI tool MARQO enhances the processing of tumor slides, boosting...

Recent biopharma financing and royalty deals highlight ongoing financial dynamism within the sector. Royalty Pharma acquired BeOne’s share of Amgen’s lung cancer drug royalties for $885 million...

Scientists have identified several promising biomarkers and immune-related signatures across cancer types. Quest Diagnostics obtained FDA breakthrough designation for a colorectal cancer test...

Cutting-edge studies in regenerative biology have revealed critical mechanisms shaping tissue repair and disease modeling. Kyoto University researchers discovered a novel mitotic cohesin complex,...

The integration of artificial intelligence with multi-omics data has significantly improved predictive accuracy in prenatal and disease diagnostics. A new AI model achieves nearly 90% accuracy in...

Researchers have developed innovative, scalable methods to enhance tissue engineering and neurological interventions. McGill University scientists introduced a scalable vibration technique that...

Cutting-edge epidemiological and clinical studies elucidate the interplay between obesity, metabolic health, and disease outcomes. A landmark pediatric study associates obesity and overweight...

AbbVie has agreed to acquire Gilgamesh Pharmaceuticals' investigational psychedelic drug, bretisilocin, targeting major depression for up to $1.2 billion. This deal places AbbVie prominently in...

The FDA’s Center for Biologics Evaluation and Research has suspended the license for Valneva’s live-attenuated chikungunya vaccine, Ixchiq, citing serious safety issues including vaccine...

Walgreens reports that patients approached by its clinical trials unit are 20% more likely to enroll in studies compared to traditional referral methods. Since launching its trials business in...

Researchers have developed cutting-edge AI models integrating multi-omics data that achieve nearly 90% accuracy in predicting preterm birth, offering transformative promise for risk assessments in...

Groundbreaking studies have elucidated the role of branched-chain amino acids (BCAAs) in exacerbating diabetic kidney disease, a major complication of diabetes mellitus. Detailed mechanistic...

A regulatory shift now enables AI-enhanced coronary CT scans to measure arterial inflammation, improving early heart attack risk prediction and enabling earlier intervention. Simultaneously,...

Innovative cancer treatments are emerging including the development of CAR T-cell therapies targeting CD84 for acute myeloid leukemia and T-cell acute lymphoblastic leukemia, areas currently...

Multiple studies present new findings on microbiota and environmental impacts: research links cervicovaginal microbiome changes in HIV-positive women under antiretroviral therapy in Peru and...